Loading...
You have changed your country from
to
. Please be aware that this will change the currency in the purchasing process.
Products:Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP
Overview
Product name
Anti-MMP8 antibody - Carboxyterminal end
See all MMP8 products (12) ...
Description
Rabbit polyclonal to MMP8 - Carboxyterminal end
Specificity
Ab38990 recognises MMP8 in its carboxiterminal region. It does not recognize the smallest active form of MMP8, since the hemopexin domain is cleaved to produce this form. It also does not cross react with the other MMP family members.
Tested applications
Cross reactivity
Reacts with
Human
Immunogen
Synthetic peptide based on the carboxy terminal end of human MMP8.
(Peptide available as ab41065.)
Properties
Form
Liquid
Storage instructions
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
Storage buffer
Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol
Concentration
Concentration information loading...
Purity
Immunogen affinity purified
Clonality
Polyclonal
Isotype
IgG
Research areas
Cardiovascular >> Atherosclerosis >> Vascular Inflammation >> Leukocyte recruitment >> Other
Cancer >> Tumor biomarkers >> Enzymes >> MMPs
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP
Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP
Applications
Show applications key
Our Abpromise guarantee covers the use of ab38990 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB
Application notes
WB: Recommended starting dilution of 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 when using chemiluminescent substrates. Predicted molecular weight: 53 kDa. When used against the reduced protein, ab38990 identifies bands at 64 kDa, 58 kDa, and a series of further cleaved active forms. Note: MMP8 levels in quiescent cells and tissues are minimal and mitogen stimulation or protein concentration is often needed to visualize the bands. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
Target
Function
Can degrade fibrillar type I, II, and III collagens.
Tissue specificity
Neutrophils.
Sequence similarities
Belongs to the peptidase M10A family.
Contains 4 hemopexin-like domains.
Domain
The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
Cellular localization
Cytoplasmic granule. Secreted > extracellular space > extracellular matrix. Stored in intracellular granules.
Target information above from: UniProt accessionP22894
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Alternative names
- CLG 1 antibody
- CLG 1 antibody
- CLG1 antibody
see all
Database links
- Entrez Gene: 4317 Human
- Omim: 120355 Human
- SwissProt: P22894 Human
- Unigene: 161839 Human
Protocols
References for Anti-MMP8 antibody - Carboxyterminal end (ab38990)
ab38990 has not yet been referenced specifically in any publications.
Publishing research using ab38990? Please let us know so that we can cite the reference in this datasheet
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"